➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Dow
Baxter
AstraZeneca
Express Scripts

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Solithromycin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Solithromycin?

Solithromycin is an investigational drug.

There have been 11 clinical trials for Solithromycin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Pneumonia, Bacterial, Pneumonia, and Gonorrhea. The leading clinical trial sponsors are Cempra Inc, National Institute of Allergy and Infectious Diseases (NIAID), and Department of Health and Human Services.

There are one hundred and six US patents protecting this investigational drug and eight hundred and eighteen international patents.

Recent Clinical Trials for Solithromycin
TitleSponsorPhase
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial PneumoniaCempra IncPhase 2/Phase 3
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without CirrhosisCempra IncPhase 2
A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseCempra IncPhase 2

See all Solithromycin clinical trials

Clinical Trial Summary for Solithromycin

Top disease conditions for Solithromycin
Top clinical trial sponsors for Solithromycin

See all Solithromycin clinical trials

US Patents for Solithromycin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Solithromycin   Get Started Free Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA)   Get Started Free
Solithromycin   Get Started Free Hamamelitannin analogues and uses thereof UNIVERSITEIT GENT (Ghent, BE)   Get Started Free
Solithromycin   Get Started Free Pharmaceutical composition for the treatment of multi-drug resistant infections Council of Scientific & Industrial Research (New Delhi, IN)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKesson
Johnson and Johnson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.